Next-Generation Sequencing Data Analysis Market Analysis Report By Product, By Workflow, By Mode, By Read Length, By End-use, By Region And Segment Forecasts From 2021 To 2028

Synopsis

The global next-generation sequencing data analysis market was prized by USD 561.4 million in 2020. It is estimated to witness a 15.02% CAGR from 2021 to 2028.

Drivers

Next-generation sequencing (NGS) has efficiently supported learning genomic along with epigenomic prototypes, linked with a variety of biological procedures. The problems about accessing, storage space, and organization of information are estimated to offer the market, by way of possible R&D openings, thus powering the enlargement of the market for next-gen sequencing data analysis.

The research societies, which make use of the superior throughput sequencers, insist on Laboratory Information Management Systems (LIMS) for managing as well as archiving sequencing information.

Cloud-sourced platforms present a constructive way out for the computationally-intensive responsibilities for the period of examination of next-gen sequencing information. As a result, it has turn into a fast and simple method for the acquirement of computational resources, to carry out next-gen sequencing information scrutiny, on a big level. Therefore, the expansion of the cloud-sourced bioinformatics stage, together with the services for significant next-gen sequencing data analysis, is anticipated to impel the next-gen sequencing data analysis market, at a quick speed.

Read Length Insight

Short-read sequencing held the 77.37% share and led the global next-generation sequencing data analysis market, in 2020, due to the extensive acceptance and easiness of use of alliance tools along with the algorithms, for short-read sequencing data.

The market demonstrates profitable openings for long as well as very long read sequencing sectors. Oxford Nanopore presented Guppy; it is a toolkit for processing the data, which comprises bioinformatics post-processing characteristics and base-calling algorithms.

Mode Insight

In 2020, the in-house mode sector held the major, more than 65.0% revenue share of the NGS data analysis market. The in-house mode comprises companies that are concerned with the testing of sickness as well as diagnosis, using next-gen sequencing, whilst carrying out their individual scrutiny via existing software and tools.

The outsourced model section is expected to record the highest CAGR, during the forecast period. Taking into consideration the price advantages presented by the outsourcing model, companies, like SciBerg, propose outsourced next-gen sequencing data analysis services.

Workflow Insight

The tertiary workflow sector held, above 48.0% revenue share and led the market; in 2020. A variety of annotation tools are operated for next-gen sequencing tertiary data analysis, in addition to companies are accepting tactical plans to increase the capacity of these tools.

Secondary data analysis is likely to be the highest increasing workflow sector, during the forecast period. The increasing use of whole-genome sequencing needs quicker resulting examination tools, to complete the growing demand.

Product Insight

Using holding more than 54.0% revenue share, services dominated the global market, in 2020. Gainful next-gen sequencing data analysis services are willingly accepted by organizations, which have a short of necessary infrastructure for data interpretation, management, and analysis.

Even though the analytical software division seized a lesser share of the market, in 2020, due to the growth in alertness regarding the sequencing tools and greater demand it is estimated to observe the highest CAGR, during the forecast period.

End-Use Insight

In 2020, the academic research sector held the major, above 53.0% revenue share of the next-generation sequencing data analysis market, attributable to growth in the acceptance of next-generation sequencing data analysis workflows, in educational establishments.

The clinical research sector is expected to record the highest CAGR, throughout the forecast period. Research programs for the growth of in vitro examination, through sequencing tools, are likely to power the expansion in clinical research.

Regional Insight

In 2020, North America retained a leading 50.03% share of the global market for next-gen sequencing data analysis. This can be credited to the attendance of a large number of important players, for example, Agilent Technologies, Illumina, Thermo Fisher Scientific along with several companies, which integrate software for the data analysis. A considerable figure of next-gen sequencing research plans is carried out in Canadian as well as U.S. universities. This augments the demand for next-gen sequencing software tools.

The Asia Pacific is expected to be the highest rising regional market, during the forecast period. Through the utilization of sequencing technologies, in Japan, there has been considerable advancement in the perception of the molecular source of cancer. The health ministry of Japan has accepted several cancer gene panels, based on next-gen sequencing tools, to be an exercise in the clinical procedures.

Companies

Two key players operating in the market are QIAGEN and Illumina. The software platform presented for the data analysis by QIAGEN is helpful at every one phase of the workflow. Besides, main companies have got hold of minor companies, to strengthen their attendance in the market.

Some of the companies for the next-gen sequencing data analysis market are:

    • Golden Helix, Inc.
    • DNAnexus Inc.
    • Fabric Genomics, Inc.
    • DNASTAR, Inc.
    • Eurofins Scientific
    • Intrexon Bioinformatics Germany GmbH
    • Bio-Rad Laboratories, Inc.
    • F. Hoffmann-La Roche Ltd.
    • QIAGEN
    • SciGenom Labs Pvt. Ltd.
    • Genuity Science
    • Congenica Ltd.
    • Pacific Biosciences of California, Inc.
    • Partek, Inc.
    • PierianDx
    • Agilent Technologies, Inc.
    • Illumina, Inc.
    • Thermo Fisher Scientific, Inc.

Report Scope

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2028. For this study, Million Insights has segmented the global next-generation sequencing data analysis market report based on product, workflow, mode, read length, end-use, and region:

• Product Outlook (Revenue, USD Million, 2017 - 2028)
    • Services
    • NGS Commercial Software
        • Platform OS/UI
        • Analytical Software
            • Alignment Tools & Software
                • DNA Seq Alignment
                • RNA Seq Alignment
                • Protein Seq Alignment
            • QC/Pre-processing Tools
            • Others

• Workflow Outlook (Revenue, USD Million, 2017 - 2028)
    • Primary
    • Secondary
        • Read Mapping
        • Variant Alignment & Variant Calling
    • Tertiary
        • Variant Annotation
        • Application-specific
            • Targeted Sequencing/Gene Panel
            • Exome Sequencing
            • RNA Sequencing
            • Whole Genome Sequencing
            • ChIP-sequencing
        • Others

• Mode Outlook (Revenue, USD Million, 2017 - 2028)
    • In-house
    • Outsourced

• Read Length Outlook (Revenue, USD Million, 2017 - 2028)
    • Short Read
    • Long Read
    • Very Long Read

• End-use Outlook (Revenue, USD Million, 2017 - 2028)
    • Academic Research
    • Clinical Research
    • Hospitals & Clinics
    • Pharma & Biotech Entities
    • Other Users

• Regional Outlook (Revenue, USD Million, 2017 - 2028)
    • North America
        • U.S.
        • Canada
    • Europe
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
    • The Asia Pacific
        • Japan
        • China
        • India
        • Australia
        • South Korea
    • Latin America
        • Brazil
        • Mexico
    • Middle East Africa (MEA)
        • South Africa
        • Saudi Arabia